ED vs ESPR · P/E 18, rev $15.26B vs rev $332.3M
Consolidated Edison Inc (ED) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the ED and ESPR stock pages for the full models.
Not investment advice.